Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Total 13F shares
-
162,897,398
-
Share change
-
-2,010,640
-
Total reported value
-
$5,472,194,669
-
Put/Call ratio
-
177%
-
Price per share
-
$33.60
-
Number of holders
-
340
-
Value change
-
-$66,824,317
-
Number of buys
-
173
-
Number of sells
-
133
Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q1 2019
As of 31 Mar 2019,
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by
340 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
162,897,398 shares.
The largest 10 holders included
FMR LLC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, OppenheimerFunds, Inc., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., STATE STREET CORP, JANUS HENDERSON GROUP PLC, GEODE CAPITAL MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
341
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.